This document discusses the need for pharmaceutical companies to build ecosystems to address "wicked problems" in healthcare. It notes that ecosystems require collaboration between many stakeholders to find solutions. It also highlights some trends in digital therapeutics, focusing on patients and providers, and issues around data governance. The document advocates that pharmaceutical companies get out of their buildings through various programs like innovation labs and hackathons to collaborate externally and build ecosystems.